Amgen
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $9,167,000 | $8,149,000 | $9,086,000 | $8,503,000 |
Gross Profit | 6,156,000 | 5,181,000 | 5,974,000 | 5,193,000 |
EBITDA | 3,617,000 | 4,083,000 | 2,926,000 | 5,273,000 |
EBIT | 2,276,000 | 2,696,000 | 1,529,000 | 3,877,000 |
Net Income | 1,432,000 | 1,730,000 | 627,000 | 2,830,000 |
Net Change In Cash | 9,167,000 | 8,149,000 | 9,086,000 | 8,503,000 |
Free Cash Flow | 1,911,000 | 980,000 | 4,400,000 | 3,314,000 |
Cash | 8,028,000 | 8,810,000 | 11,973,000 | 9,011,000 |
Basic Shares | 541,000 | 541,000 | 542,000 | 542,000 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $33,424,000 | $28,190,000 | $26,323,000 | $25,979,000 |
Gross Profit | 20,566,000 | 19,739,000 | 19,917,000 | 19,525,000 |
EBITDA | 13,356,000 | 7,897,000 | 12,169,000 | 11,296,000 |
EBIT | 7,764,000 | 7,897,000 | 8,752,000 | 7,898,000 |
Net Income | 4,090,000 | 6,717,000 | 6,552,000 | 5,893,000 |
Net Change In Cash | 33,424,000 | 28,190,000 | 26,323,000 | 25,979,000 |
Cost of Revenue | -360,000 | 1,723,000 | ||
Free Cash Flow | 10,394,000 | 7,359,000 | 8,785,000 | 8,381,000 |
Cash | 11,973,000 | 10,944,000 | 7,629,000 | 7,989,000 |
Basic Shares | 541,000 | 538,000 | 541,000 | 573,000 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-06-30 | $6.02 |
2025-03-31 | $4.90 |
2024-12-31 | $5.31 |
2024-09-30 | $5.58 |
